Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes - Wikidata - wikimedia - TriplyDB

Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes

Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes

http://www.wikidata.org/entity/Q34260018

about

The potential use of biomarkers in predicting contrast-induced acute kidney injury The effects of environmental chemicals on renal function Progression after AKI: Understanding Maladaptive Repair Processes to Predict and Identify Therapeutic Treatments.Performance Characteristics of Kidney Injury Molecule-1 In Relation to Creatinine, Urea, and Microalbuminuria in the Diagnosis of Kidney Disease Postoperative acute kidney injury Diabetic nephropathy - complications and treatment.Circulating Kidney Injury Molecule 1 Predicts Prognosis and Poor Outcome in Patients With Acetaminophen-Induced Liver Injury Target biomarker profile for the clinical management of paracetamol overdose.Potential diagnostic biomarkers for chronic kidney disease of unknown etiology (CKDu) in Sri Lanka: a pilot study.Diagnostic Value of Urine Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 for Acute Kidney Injury: A Meta-Analysis.Increased plasma kidney injury molecule-1 suggests early progressive renal decline in non-proteinuric patients with type 1 diabetes.A potential adjuvant chemotherapeutics, 18β-glycyrrhetinic acid, inhibits renal tubular epithelial cells apoptosis via enhancing BMP-7 epigenetically through targeting HDAC2.PROGRESSION OF CHRONIC KIDNEY DISEASE AFTER ACUTE KIDNEY INJURY.ABT-719 for the Prevention of Acute Kidney Injury in Patients Undergoing High-Risk Cardiac Surgery: A Randomized Phase 2b Clinical Trial.Novel Tubular Biomarkers Predict Renal Progression in Type 2 Diabetes Mellitus: A Prospective Cohort Study.Ectopic Adipose Tissue Storage in the Left and the Right Renal Sinus is Asymmetric and Associated With Serum Kidney Injury Molecule-1 and Fibroblast Growth Factor-21 Levels Increase.Role of Renal Sinus Adipose Tissue in Obesity-induced Renal Injury.Updating the natural history of diabetic nephropathy.Renal allograft fibrosis: biology and therapeutic targets.Predicting acute kidney injury: current status and future challenges.Diabetic Kidney Disease in Adolescents With Type 2 Diabetes: New Insights and Potential Therapies.Kidney Injury Molecule-1 is Elevated in Nephropathy and Mediates Macrophage Activation via the Mapk Signalling Pathway.Recent advances in biomarkers and therapeutic interventions for hepatic drug safety - false dawn or new horizon?Stop adding insult to injury-identifying and managing risk factors for the progression of acute kidney injury in children.The Promise of Mesenchymal Stem Cell Therapy for Diabetic Kidney Disease.Do serum and urinary concentrations of kidney injury molecule-1 in healthy newborns depend on birth weight, gestational age or gender?The next generation of therapeutics for chronic kidney disease Kidney injury molecule-1 in kidney disease.New insights in molecular mechanisms involved in chronic kidney disease using high-resolution plasma proteome analysis.Biomarkers for the Early Detection and Prognosis of Acute Kidney Injury.A perspective on chronic kidney disease progression.Plasma Biomarkers and Kidney Function Decline in Early and Established Diabetic Kidney Disease.Emerging biomarkers of chronic kidney disease in children.Effects of linagliptin on renal endothelial function in patients with type 2 diabetes: a randomised clinical trial.Common chronic conditions do not affect performance of cell cycle arrest biomarkers for risk stratification of acute kidney injury.Late intervention with the small molecule BB3 mitigates postischemic kidney injury.αKlotho and Chronic Kidney Disease.Performance of urinary kidney injury molecule-1, neutrophil gelatinase-associated lipocalin, and N-acetyl-β-D-glucosaminidase to predict chronic kidney disease progression and adverse outcomes.Urine Kidney Injury Biomarkers and Risks of Cardiovascular Disease Events and All-Cause Death: The CRIC Study.Circulating kidney injury molecule-1 is a novel diagnostic biomarker for renal dysfunction during long-term adefovir therapy in chronic hepatitis B.

P2860

Q28078393-1DCD701D-5746-4EAE-82B5-BE2FF606ADF9 Q28397401-3658B06A-7737-4888-BA00-85684655CEB0 Q30278441-610F82DE-33B9-4784-BA03-0FE800E94175 Q33718114-6EC400DD-E0A7-469E-B036-5B07AB049DF4 Q33752663-75FFE4FB-B641-40C5-B4F3-2C21E4D648FD Q34387952-69A5239C-8F01-4E76-A4E7-B726EA2A4B64 Q35889291-C9C449AA-0FA6-4367-93AF-7F6E21CB1AAE Q36072453-670A61C6-6783-4BCE-91C3-C2187B7C37C9 Q36254591-29657558-061E-4BB0-A0EC-2668B247A2D0 Q36255818-23ECDBC8-829A-4683-B44D-C4950C9C5F84 Q36844894-10858D03-72C3-40B1-8F05-4A4812E072E8 Q36870776-F629FB33-CAC6-4097-BAF4-4F00A1862898 Q37092343-194D0E2E-661F-4909-8493-0DCE4EC17949 Q37240378-745A41F3-369E-4EF5-A632-3B0A0EB72BDE Q37273724-71D60A51-F50A-41C8-8ECE-D58F33BC624D Q37604619-4AE2E476-ED85-44CE-AE6B-1526D1EDE632 Q37604920-0C0F414F-2066-4D9E-B446-BA9606175E28 Q38258271-5A4178FD-46BB-4294-A522-13BE7CCF7E09 Q38359455-AEA0248D-1D60-4C01-B91F-58AB2C596E5E Q38669818-97C00BA3-C81B-45E0-BB2F-1D59F6AFBA2D Q38709338-1260D768-CC38-4CC9-A834-DB6AE65967CD Q38715872-E428D388-306A-4F83-A85B-D25CA50D7870 Q38753644-D88B3806-5DF3-4FB0-8D27-9CE0BF244915 Q38757482-A4C6ED0F-395E-4F74-8EF5-DE47405E39C7 Q38786133-C7379C5C-6FBA-49A6-B451-BCBFA3E908F5 Q38816521-3B4871DD-2C3B-46E2-BE84-60FDAFE8ABF0 Q38845590-B8CC274F-8634-48D4-8DD3-D2DD68A7667E Q38985062-A5729026-DAB6-40D8-B51F-2C7FE0A14048 Q38986294-B88AA45C-CF98-4F66-B0FE-F6CB6DC10C78 Q39003626-68EEF226-0D13-487F-96D6-860A071E1D25 Q39038570-848FCE1D-1E46-43C5-B70C-05E534F8B161 Q39286825-D8BB969D-40C8-4FF7-B49C-9630DC036B23 Q39380540-5F187D59-8F61-409B-A59F-B54FCD1C7DBC Q39430700-2FE51CE9-4AA5-4AFE-9167-66D93A1499CF Q39656497-8A418585-EB8F-4456-9E5C-91207BC2D22F Q39716356-9D85A7A3-6C98-4194-BC32-B7064A3FD4AB Q39812781-A7068284-55E5-41CE-9A4D-9CA82657DEBC Q40256539-77B96E93-B57C-47E8-A885-2ABB20FC317B Q40310730-96301D2C-387A-449F-B3A0-78C0A26CE816 Q40446757-440D822D-E7B8-42CE-B6F9-6114768467E2

P2860

Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes

http://www.wikidata.org/entity/Q34260018

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Blood kidney injury molecule-1 ...... ion to ESRD in type I diabetes

@ast

Blood kidney injury molecule-1 ...... ion to ESRD in type I diabetes

@en

Blood kidney injury molecule-1 ...... ion to ESRD in type I diabetes

@nl

type

label

Blood kidney injury molecule-1 ...... ion to ESRD in type I diabetes

@ast

Blood kidney injury molecule-1 ...... ion to ESRD in type I diabetes

@en

Blood kidney injury molecule-1 ...... ion to ESRD in type I diabetes

@nl

prefLabel

Blood kidney injury molecule-1 ...... ion to ESRD in type I diabetes

@ast

Blood kidney injury molecule-1 ...... ion to ESRD in type I diabetes

@en

Blood kidney injury molecule-1 ...... ion to ESRD in type I diabetes

@nl

P1433

Q34260018-61E47946-053B-419E-BDD0-48124A31EA77

P1476

Q34260018-D80EA0B7-5FBF-4463-A883-5071799CF9BD

P2093

Q34260018-11134F38-9D7E-4833-8963-59BD2908001E

Q34260018-5F935B2E-CB2A-4D38-BD66-363BF1A9DD1D

Q34260018-627EF382-2553-4570-9697-F48378BF6775

Q34260018-669E3B98-68F5-4824-B88E-74FC18F3F2D3

Q34260018-6AEEB856-8413-4781-AA9F-FD741F0DE84D

Q34260018-780CED3B-02CF-49C5-8A86-697886690640

Q34260018-78E380DD-C80D-4267-884F-681D6F9EB778

Q34260018-790A6DFA-7A69-427A-AF0D-FFC116DB7AEE

Q34260018-7B53FB56-4B46-4A15-BF19-E109CAE80A2A

Q34260018-8CEFE7EE-4E8F-430E-A1A6-DC903BC5664A

P2860

Q34260018-051444D2-33D4-432D-B098-4B2E3012EEA5

Q34260018-15BB1A27-7937-42BA-A4BB-5A046E07125E

Q34260018-1EDF0BE1-8049-4930-A23A-2E6784D7A073

Q34260018-28EAF58B-8609-4010-BF57-5DB4C833DEE1

Q34260018-3943BB2F-2983-48D7-A016-6F672BA793D9

Q34260018-4CA1AC73-3F4B-4BAB-B798-F3FB8769FD0F

Q34260018-5336C707-F878-4A08-A5AA-1D3965C6A655

Q34260018-5D391080-6E40-491C-AF34-17A4505856A0

Q34260018-5EE91BB9-DDCF-407A-BE73-531499E65C8B

Q34260018-60FB2362-DA63-42A1-AF45-DC0F11AE4C4A

P304

Q34260018-E7858561-2C6E-4D52-AB41-0D71BE02AC8B

P31

Q34260018-F0A44462-CD8A-4AE9-B68E-3EA552CD42B3

P356

Q34260018-F4D5606C-BA9E-4E51-9280-7A850F79D1A3

P433

Q34260018-F6A22DEC-F4EB-4972-8E5E-13EC433023F3

P478

Q34260018-34EBAE77-4ED7-4249-9ABC-B740159C8C15

P577

Q34260018-D1083238-A55E-46F9-AA26-FE5BD6CDC7BB

P5875

Q34260018-D08ECD7A-ECEF-46EA-97B4-95C5BB3490F5

P698

Q34260018-42842486-E842-4397-9467-5D2E9F0BCBB9

P921

Q34260018-45D7DC49-0285-48E0-8902-E1A136BAC61B

Q34260018-FD5F0719-A6DE-4676-976D-25EA0A874751

P932

Q34260018-BCD65F6D-B530-4F7B-8EDC-4BC2F088ADA5

P356

P1433

Journal of the American Society of Nephrology

P1476

Blood kidney injury molecule-1 ...... ion to ESRD in type I diabetes

@en

P2093

Abinaya Ravisankar

http://www.w3.org/2001/XMLSchema#string

Adam Smiles

http://www.w3.org/2001/XMLSchema#string

Andrzej S Krolewski

http://www.w3.org/2001/XMLSchema#string

Chang Wang

http://www.w3.org/2001/XMLSchema#string

Daniel J Antoine

http://www.w3.org/2001/XMLSchema#string

James W Dear

http://www.w3.org/2001/XMLSchema#string

Joseph V Bonventre

http://www.w3.org/2001/XMLSchema#string

Kazumi Ito

http://www.w3.org/2001/XMLSchema#string

Kevin B Park

http://www.w3.org/2001/XMLSchema#string

Mark Radlinski

http://www.w3.org/2001/XMLSchema#string

P2860

The human homolog of HAVcr-1 codes for a hepatitis A virus cellular receptor

Tubular kidney injury molecule-1 in protein-overload nephropathy

Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies.

A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

Normalization of urinary biomarkers to creatinine during changes in glomerular filtration rate

Risk for ESRD in type 1 diabetes remains high despite renoprotection.

Microvascular endothelial injury and dysfunction during ischemic acute renal failure.

The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end-stage renal disease.

Targeted proximal tubule injury triggers interstitial fibrosis and glomerulosclerosis

Novel assays for detection of urinary KIM-1 in mouse models of kidney injury

P304

2177-2186

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2013070758

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262930180

http://www.w3.org/2001/XMLSchema#string

P698

24904085

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

P932

4178434

http://www.w3.org/2001/XMLSchema#string